REQUEST A DEMO
Total
USD $0.00
Search more companies

Isomed Pharma Colombia S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Isomed Pharma Colombia S.A.S. Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Isomed Pharma Colombia S.A.S. is an enterprise based in Colombia. Its main office is in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on May 04, 2016. The total number of employees is currently 9 (2025). From the latest financial highlights, Isomed Pharma Colombia S.A.S. reported a net sales revenue increase of 13.68% in 2024. There was a total growth of 10.93% in Isomed Pharma Colombia S.A.S.’s total assets over the same period. In 2024, Isomed Pharma Colombia S.A.S.’s net profit margin decreased by 13.87%.

Headquarters
Cl 93 # 11 A - 28 Of 601
Bogota D.C.; Bogota D.C; Postal Code: 0808

Contact Details: Purchase the Isomed Pharma Colombia S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Isomed Pharma Colombia S.A.S. report to view the information.
Financial Auditors:
Purchase the Isomed Pharma Colombia S.A.S. report to view the information.
Incorporation Date:
May 04, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Isomed Pharma Colombia S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
13.68%
Total operating revenue
13.68%
Operating profit (EBIT)
-96.9%
Net Profit (Loss) for the Period
-96.9%
Total Assets
10.93%
Total Equity
3.34%
Operating Profit Margin (ROS)
-13.87%
Net Profit Margin
-13.87%
Return on Equity (ROE)
-104.3%
Quick Ratio
-2.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?